bendroflumethiazide has been researched along with doxazosin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ebbs, D | 1 |
| Brown, MJ; Deary, AJ; Foo, RS; Haydock, SF; Murfet, H; Schumann, AL | 1 |
| Collins, B; Hobbs, FR; Khan, T | 1 |
1 review(s) available for bendroflumethiazide and doxazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for bendroflumethiazide and doxazosin
| Article | Year |
|---|---|
A comparison of selected antihypertensives and the use of conventional vs ambulatory blood pressure in the detection and treatment of hypertension.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Diastole; Double-Blind Method; Doxazosin; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Systole; Treatment Outcome | 2001 |
Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Natriuretic Peptide, Brain; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors | 2002 |
Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Asia, Southeastern; Bendroflumethiazide; Blood Glucose; Cholesterol; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; United Kingdom | 2005 |